Journal Information
Original Article
Full text access
Pre-proof, online 2 September 2025
Analysis of effectiveness of clinical psychological care protocol for smoking cessation with cytisinicline
Visits
9
Angela Ramos-Pinedo1,
, Jose Ignacio de Granda-Orive2, Maria Isabel Cristóbal-Fernández3, Calos Rábade-Castedo4, Elia Pérez-Fernández5, Paz Vaquero-Lozano6, Maria Inmaculada Gorordo-Unzueta7, Lourdes Lázaro-Asegurado8, Eva de Higes-Martínez9, Juan Antonio Riesco-Miranda10, Rosa Mirambeaux-Villalona11, Gloria Francisco-Corral12, Alejandro Frino-García13, Jaime Signes-Costa Miñana14, Cristina Villar-Laguna15, Ana Maria Cicero-Guerrero16, Julio Cesar Vargas-Espinal17, Teresa Peña-Miguel18, Jacobo Sellares19, Carlos Andrés Jiménez-Ruiz20
1 Unidad de Neumología, Hospital Universitario Fundación Alcorcón, Madrid, Spain
2 Senior lecturer. Medicine Department, School of Medicine. Complutense University. Respiratory Department. 12 of October University Hospital, Madrid, Spain
3 Psicóloga Sanitaria. Unidad especializada en tabaquismo de la Comunidad de Madrid. Hospital Clínico San Carlos, Madrid, Spain
4 Unidad Especializada de Tabaquismo. Servicio de Neumologia. Hospital Clínico Universitario de Santiago de Compostela, La Coruña, Spain
5 MSc. Unidad de Investigación. Hospital Universitario Fundación Alcorcón, Madrid, Spain
6 MSc. Enfermera Respiratoria. EPA en Tabaquismo. CEP Hermanos Sangro. Hospital General Universitario Gregorio Marañón, Madrid, Spain
7 Servicio de Neumología, Hospital Universitario Galdakao-Usánsolo, Bizkaia, Spain
8 Servicio de Neumología, Complejo Asistencial Universitario de Burgos, Spain
9 Unidad de Neumología, Hospital Universitario Fundación Alcorcón, Madrid, Spain
10 Servicio de Neumologia. Hospital Universitario de Cáceres, Spain
11 Servicio de neumología. Hospital Universitario Ramón y Cajal, Madrid, Spain
12 Servicio de Neumología. Hospital General Universitario Mancha Centro, Spain
13 Consulta Multidisciplinaria de Alta Complejidad en Tabaquismo. Servicio de Neumología, Hospital Clínic de Barcelona, Spain
14 Servicio de Neumología. Hospital Clínico. Universidad de València. INCLIVA, Valencia, Spain
15 DUE en Unidad Especializada en Tabaquismo de Madrid. Hospital Universitario Clínico San Carlos, Madrid, Spain
16 Unidad Especializada en Tabaquismo de Madrid. Hospital Universitario Clínico San Carlos, Madrid, Spain
17 Neumología. Unidad de Tabaquismo. CEP Hermanos Sangro. Hospital General Universitario Gregorio Marañón, Madrid, Spain
18 Servicio de Neumología, Complejo Asistencial Universitario de Burgos, Spain
19 Servicio de Neumología. Hospital Clinic. Barcelona. Sapin, Spain
20 Neumólogo Experto en Tabaquismo, Spain
Ver más
This item has received
Article information
Abstract

Objectives: The main objective was to analyze the short, medium, and long-term effectiveness of a clinical-psychological care protocol for smoking cessation using cytisinicline. Other secondary objectives were evaluate safety and whether the characteristics of smoking, adherence, and the intensity of craving and withdrawal syndrome at 4th week were associated with effectiveness,

Methods: Observational, prospective, multicenter study that includes smokers motivated to quit evaluated in twelve Smoking Cessation Services in Spain.

Results: A total of 337 smokers were studied. Effectiveness of cytisinicline was 68% at the end of treatment, but was reduced to 48.7%, 40.9% and 28.2%, at 3rd, 6th and 12th month of follow up respectively. The measurement of adherence and the intensity of craving by SRC showed statistically significant association with effectiveness at 24th week, RRadj=2.2 (p<0.001) and RRadj=0.87 (p=0.011) respectively. Common adverse effects (occurring in more than 10% of patients) were: sleep disorders, headaches, dizziness and digestive disorders.

Conclusions: The effectiveness of protocol was 68% at the end of treatment, but was reduced to 48.7%, 40.9% and 28.2% at 3rd, 6th and 12th months respectively. Subjects who met more than 80% of treatment adherence doubled their chances of success at 6th month. For each point of craving intensity, measured by the SRC, at the end of the pharmacological treatment the chances of success at 6th month were reduced by 13%. Cytisinicline was safe.

Key words:
Smoking cessation
cytisinicline
effectiveness
adverse effects
clinical psycological care protocol
Full text is only available in PDF
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?